Treatment with elexacaftor/tezacaftor/ivacaftor does not alter SpiroNose-derived electronic breath profiles in children with cystic fibrosis. // Journal of Cystic Fibrosis. – URL: https://www.sciencedirect.com/science/article/pii/S1569199326000810?dgcid=rss_sd_all
Treatment with elexacaftor/tezacaftor/ivacaftor does not alter SpiroNose-derived electronic breath profiles in children with cystic fibrosis. Journal of Cystic Fibrosis. https://www.sciencedirect.com/science/article/pii/S1569199326000810?dgcid=rss_sd_all
“Treatment with elexacaftor/tezacaftor/ivacaftor does not alter SpiroNose-derived electronic breath profiles in children with cystic fibrosis.” Journal of Cystic Fibrosis.
@article{article117077,
title = {Treatment with elexacaftor/tezacaftor/ivacaftor does not alter SpiroNose-derived electronic breath profiles in children with cystic fibrosis},
journal = {Journal of Cystic Fibrosis},
url = {https://www.sciencedirect.com/science/article/pii/S1569199326000810?dgcid=rss_sd_all}
}
ABSTRACT Aim To investigate the longitudinal association between early‐life movement behaviour patterns and later clinically diagnosed obesity. Method In the population‐based All Babies in Southeast Sweden (ABIS) cohort, 16 415 children...